All In MedTech

Device Trial Radar · NCT00971087

Multicenter Hologic Tomosynthesis Study

A Multicenter, Controlled Clinical Trial to Evaluate the Hologic Tomosynthesis Mammography

Last checked: Nov 20, 2026Latest source record: Feb 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

3,521

Actual

Start

Sep 2009

Primary completion

Sep 2011

Study completion Apr 2012

Sponsor

Lead sponsor
Hologic, Inc.Public (HOLX)
Sponsor type
Industry
First posted
Sep 3, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Screening
Who can join
Female only, from 18 years, up to 110 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Synthetic 2D images, generated from the tomosynthesis image, will be available to the readers to provide an over view of the anatomy similar to a scout view in CT imaging and to determine whether the 3-D images with the synthesized 2D overview are non-inferior to the 2-D images alone as determined by receiver operating characteristic (ROC) area under the curve.

Conditions

  • Breast Cancer

Interventions

  • Hologic Selenia Dimensions Digital Breast Tomosynthesis SystemDevice

    Subjects are exposed to the same number of investigational images collected on the investigational device (Selenia Dimensions Full Field Digital Mammography System). Subject enrollment occurs at the time subjects are being imaged for their standard of care mammographic work up (either screening mammogram or scheduled biopsy). All subjects undergoing a biopsy procedure will be imaged on the investigational device prior to their procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To Demonstrate Non-inferior ROC Performance as Measured by the Area Under the Curve When Comparing 3-Ds Plus 3-D Images to the 2-D Images.Time frame: At time of exam

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Scottsdale Medical Imaging Ltd. (SMIL)

    Scottsdale, Arizona

  • Hoag Memorial Hospital

    Newport Beach, California

  • UC Davis

    Sacramento, California

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.